These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27859603)

  • 1. Congenital erythropoietic porphyria: mild presentation with late onset associated with a mutation in the UROS gene promoter sequence.
    Fityan A; Fassihi H; Sarkany R
    Clin Exp Dermatol; 2016 Dec; 41(8):953-954. PubMed ID: 27859603
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling.
    Ged C; Mégarbané H; Chouery E; Lalanne M; Mégarbané A; de Verneuil H
    J Invest Dermatol; 2004 Sep; 123(3):589-91. PubMed ID: 15304101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel UROS mutation in a Chinese patient affected by congenital erythropoietic porphyria.
    Guo S; Wang L; Li X; Nie G; Li M; Han B
    Blood Cells Mol Dis; 2014 Jan; 52(1):57-8. PubMed ID: 23953398
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital erythropoietic porphyria, description of a new mutation in two brothers.
    Moruno Tirado A; Herrera Saval A; Martinez Montero E; Hernandez Hazanas F; Ceballos Aragon J; Ged C; de Verneuil H
    Eur J Pediatr; 1997 Oct; 156(10):817-8. PubMed ID: 9365077
    [No Abstract]   [Full Text] [Related]  

  • 5. A molecular study of congenital erythropoietic porphyria in cattle.
    Agerholm JS; Thulstrup PW; Bjerrum MJ; Bendixen C; Jørgensen CB; Fredholm M
    Anim Genet; 2012 Apr; 43(2):210-5. PubMed ID: 22404357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Atypical Case of Congenital Erythropoietic Porphyria.
    Sudrié-Arnaud B; Legendre M; Snanoudj S; Pelluard F; Bekri S; Tebani A
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria.
    Wiederholt T; Poblete-Gutiérrez P; Gardlo K; Goerz G; Bolsen K; Merk HF; Frank J
    Physiol Res; 2006; 55 Suppl 2():S85-92. PubMed ID: 17298225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family.
    Takamura N; Hombrados I; Tanigawa K; Namba H; Nagayama Y; de Verneuil H; Yamashita S
    Am J Med Genet; 1997 Jun; 70(3):299-302. PubMed ID: 9188670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity for a premature termination codon and missense mutation in the exon 10 of the uroporphyrinogen III cosynthase gene causes a severe phenotype of congenital erythropoietic porphyria.
    Kang TW; Oh SW; Kim MR; Lee JS; Kim SC
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):470-1. PubMed ID: 18647208
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of mutations in the uroporphyrinogen III synthase gene in a Thai girl patient with congenital erythropoietic porphyria.
    Glomglao W; Treesucon A; Roothumnong E; Thongnoppakhun W; Siraprapapat P; Suwanthol L; Sanpakit K; Tanphaichitr VS
    Int J Lab Hematol; 2015 Apr; 37(2):e44-7. PubMed ID: 25092523
    [No Abstract]   [Full Text] [Related]  

  • 11. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
    To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
    Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.
    Moghbeli M; Maleknejad M; Arabi A; Abbaszadegan MR
    Mol Biol Rep; 2012 Jun; 39(6):6731-5. PubMed ID: 22350154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.
    Solis C; Aizencang GI; Astrin KH; Bishop DF; Desnick RJ
    J Clin Invest; 2001 Mar; 107(6):753-62. PubMed ID: 11254675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital erythropoietic porphyria: bringing evidence-based practice to a rare disease.
    Sarkany R
    Br J Dermatol; 2012 Oct; 167(4):709. PubMed ID: 23013311
    [No Abstract]   [Full Text] [Related]  

  • 15. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
    Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
    Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
    Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
    Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
    Blouin JM; Bernardo-Seisdedos G; Sasso E; Esteve J; Ged C; Lalanne M; Sanz-Parra A; Urquiza P; de Verneuil H; Millet O; Richard E
    Hum Mol Genet; 2017 Apr; 26(8):1565-1576. PubMed ID: 28334762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital erythropoietic porphyria: a novel homozygous mutation in a Japanese patient.
    Rogounovitch T; Takamura N; Hombrados I; Morel C; Tanaka T; Kameyoshi Y; Shimizu-Yoshida Y; de Verneuil H; Yamashita S
    J Invest Dermatol; 2000 Dec; 115(6):1156. PubMed ID: 11121156
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital erythropoietic porphyria affecting two brothers.
    Herrera Saval A; Moruno Tirado A
    Br J Dermatol; 1999 Sep; 141(3):547-50. PubMed ID: 10583066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital erythropoietic porphyria: advances in pathogenesis and treatment.
    Desnick RJ; Astrin KH
    Br J Haematol; 2002 Jun; 117(4):779-95. PubMed ID: 12060112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.